Compare Citigroup Inc. (C) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citigroup Inc. vs Medpace Holdings Inc — how do they compare? Citigroup Inc. trades at $136.09 (market cap $227.75B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Citigroup Inc. is far larger — about 13.5× Medpace Holdings Inc's market cap, and Citigroup Inc. pays a 1.97% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| C | MEDP | |
|---|---|---|
Market Cap | $227.75B | $16.90B |
Sector | Financials | Technology |
52-Week High | $145.67 | $620.59 |
52-Week Low | $92.59 | $393.42 |
Dividend Yield | 1.97% | — |
Enterprise Value | — | $16.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citigroup Inc.
Citigroup Inc. is a diversified financial services holding company that provides a broad range of financial services to consumer and corporate customers. The Company services include investment banking, retail brokerage, corporate banking, and cash management products and services. Citigroup serves customers globally.
Read more on C →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
